The U.S. leads the global interventional radiology (IR) market in 2024, driven by a preference for minimally invasive treatments. With a forecasted CAGR of 2.3% (2025-2035), it remains a key player in advancing IR solutions.
NEWARK, DE / ACCESSWIRE / January 15, 2025 / The global interventional radiology market continues to reshape the healthcare landscape, driven by the increasing adoption of minimally invasive, image-guided procedures. According to recent projections, global sales of interventional radiology are expected to rise from USD 30,336.0 million in 2025 to an impressive USD 49,430.6 million by 2035, reflecting a compound annual growth rate (CAGR) of 5.2% during the forecast period. The market revenue stood at USD 28,775.6 million in 2024, underscoring its consistent growth trajectory.
Revolutionizing Modern Healthcare:
Interventional radiology has emerged as a transformative force in modern medicine. By leveraging cutting-edge imaging technologies, interventional radiologists can precisely guide thin catheters and guidewires through blood vessels, allowing direct delivery of medications, fluids, and nutrition into the bloodstream. These minimally invasive techniques reduce patient discomfort, limit the need for repeated needle insertions, and significantly enhance patient outcomes.
Diverse Applications Across Organ Systems:
IR procedures are integral to managing a wide range of conditions across various organ systems. One notable area of application is central venous access procedures, which constitute approximately 40% of all annual IR interventions performed in Europe. This highlights the widespread utility and critical role of interventional radiology in addressing complex medical challenges.
Driving Factors Behind Market Growth:
The projected growth of the IR market is underpinned by several key factors:
Technological Advancements: Innovations in imaging and catheter-guiding technologies have improved the accuracy and efficacy of IR procedures.
Rising Preference for Minimally Invasive Procedures: Patients and healthcare providers increasingly favor procedures that minimize recovery time and risks compared to traditional surgeries.
Expanding Applications: The versatility of interventional radiology in treating a wide array of conditions is driving its adoption across healthcare systems globally.
Future Outlook:
As the global healthcare industry continues to prioritize patient-centered and cost-effective treatment solutions, interventional radiology is well-positioned to lead the way in modern medical care. The steady growth of this market reflects its potential to address evolving healthcare needs while improving patient outcomes and overall healthcare efficiency.
Key Takeaways: Global Interventional Radiology Market
-
Market Growth:
The global interventional radiology market is projected to grow from USD 30,336.0 million in 2025 to USD 49,430.6 million by 2035, reflecting a CAGR of 5.2% during the forecast period.
In 2024, the revenue generated by the market was USD 28,775.6 million.
-
Regional Insights:
United States: Expected to achieve a 2.3% Value CAGR between 2025 and 2035.
Germany: Projected to grow at a 2.0% Value CAGR during the same period.
Italy: Anticipated to witness a 2.6% Value CAGR from 2025 to 2035.
UK: Forecasted to experience a robust growth rate with a 4.7% Value CAGR over the next decade.
India: Leading the growth trajectory with an impressive 7.4% Value CAGR from 2025 to 2035.
China: Following closely with a significant 6.9% Value CAGR over the forecast period.
Interventional Radiology Product Market set to hit worth USD 48.8 billion at CAGR 7.4% from forecast period 2024 to 2034
This data underscores the dynamic growth potential of interventional radiology across key global markets, with emerging economies like India and China outpacing others in terms of CAGR.
"Interventional radiology is rapidly gaining prominence as a cornerstone of modern medicine, driven by the global shift towards less invasive medical procedures. This market is poised to benefit from technological advancements, increased awareness, and growing demand for patient-centric solutions. With central venous access procedures dominating the intervention landscape, IR is set to redefine healthcare delivery, particularly in regions prioritizing advanced imaging and minimally invasive techniques," says Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI) analyst.
Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!
https://www.futuremarketinsights.com/reports/interventional-radiology-market
Competitive Landscape:
The interventional radiology market is intensely competitive, with established leaders and emerging innovators striving for greater market share. Industry leaders are heavily investing in advanced imaging technologies and minimally invasive solutions to solidify their positions. Meanwhile, collaborations with new players introducing disruptive innovations are reshaping traditional practices. A significant focus is on research and development of cutting-edge technologies such as AI-driven imaging, robotic-assisted interventions, and hybrid operating room systems.
Recent Developments in the Interventional Radiology Market:
December 2024: AGFA HealthCare partnered with Rad AI to revolutionize radiology workflows. The collaboration integrates Rad AI Reporting and FHIRcast with AGFA's Enterprise Imaging platform, setting a new benchmark in radiology innovation.
January 2023: Canon Medical Systems USA Inc. finalized a strategic partnership with ScImage, Inc. This partnership combines Canon Medical's diagnostic imaging expertise with ScImage's cloud-native solutions in enterprise image management, PACS, and healthcare image exchange, delivering enhanced capabilities to the healthcare sector.
Key Players of Interventional Radiology Industry:
Siemens Healthineers
GE Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical Corporation
Fujifilm Holdings Corporation
Hologic, Inc.
Agfa-Gevaert Group
Mindray Medical International
United Imaging Healthcare
Key Segments of Interventional Radiology Industry:
By Product:
In terms of product, the industry is divided into MRI systems, CT scanners, ultrasound imaging systems, angiography systems and others.
By Procedure:
In terms of procedure, the industry is divided into angioplasty, biopsy, embolization thrombolysis, vertebroplasty, nephrostomy, interventional oncology, msk intervention and others.
By Application:
In terms of application, the industry is divided into cardiology, oncology, urology, gastroenterology, obstetrics, gynecology, and others.
By End User:
In terms of end user, the industry is segregated into hospitals, clinics, ambulatory surgical centres, and others.
By Region:
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, and Middle East and Africa (MEA) have been covered in the report.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI's Related Ongoing Coverage on Healthcare Market Insights Domain:
As per the analysis of Future Market Insights, the expected development of the global nonvascular interventional radiology device market size is likely to adhere to a CAGR of 4.9%. The ecosystem is likely to get elevated from USD 27.6 billion in 2024 to the valuation mark of USD 44.6 billion by 2034.
The neurointerventional device market share is projected to be worth USD 2.6 billion in 2023. The market is likely to reach USD 4.1 billion by 2033. The market is further expected to surge at a CAGR of 4.7% during the forecast period 2023 to 2033.
Global demand for interventional cardiology devices is anticipated to record a CAGR of 8.4% during the forecast period (2022 to 2032). The interventional cardiology devices market is expected to be valued at USD 16.4 Billion in 2022 and is likely to reach USD 36.9 Billion by 2032.
The newly released personalized medicine market growth analysis report by Future Market Insights shows that global sales of the Personalized Medicine Market in 2022 were held at USD 326.7 Billion. With a CAGR of 7.8% from 2023 to 2033, the market in the country is expected to reach USD 690.9 Billion.
The sales of artificial pancreas systems in North America and Europe is set to transform diabetes management, with market valuations projected to experience exponential growth. In 2022, the market value of these advanced systems was estimated at USD 182.71 million, with a forecasted surge to USD 567.47 million by 2032, marking an impressive compound annual growth rate (CAGR) of 12% over the decade.
The global at-home testing market trends are estimated to be worth USD 7,789.1 million in 2025 and are anticipated to reach a value of USD 11,877.8 million by 2035. Sales are projected to rise at a CAGR of 4.8% over the forecast period between 2025 and 2035.
The global drug formulation market strategies are estimated to be worth USD 1.7 trillion in 2025 and are anticipated to reach a value of USD 2.8 trillion by 2035. Sales are projected to rise at a CAGR of 5.7% over the forecast period between 2025 and 2035.
The niacin and niacinamide market opportunity is estimated to reach USD 1.3 billion in 2025. It is anticipated to grow at a CAGR of 3.1% during the assessment period 2025 to 2035 and reach a value of USD 1.8 billion by 2035.
The global surgical navigation system market outlook is estimated to be worth USD 1,235.7 million in 2025 and anticipated to reach a value of USD 2,255.2 million by 2035. Sales are projected to rise at a CAGR of 6.2% over the forecast period between 2025 and 2035.
The global organ transport devices market overview are estimated to be worth USD 478.0 million in 2025 and anticipated to reach a value of USD 735.8 million by 2035. Sales are projected to rise at a CAGR of 4.9% over the forecast period between 2025 and 2035.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website:https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
SOURCE: Future Market Insights Inc.
View the original press release on accesswire.com